BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Other News

SynBio, Rusnano hematology, endocrine/metabolic, infectious news

The state-funded $10 billion nanotechnology fund Rusnano followed up on an August commitment and invested RUB900 million ($28.7 million) in biobetters company SynBio. The investment represents a 41.4% stake. SynBio is a JV formed this year by a group comprised of the fund, Russian firms the Human Stem Cells Institute (MICEX:ISKJ, Moscow, Russia),

Read the full 262 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >